Advertisement

Advertisement

AU:NX1 Stock Latest News

Nexalis Therapeutics Seeks Voluntary Suspension Pending Debt Funding Update

Company AnnouncementsNexalis Therapeutics Seeks Voluntary Suspension Pending Debt Funding Update

Nexalis Therapeutics Requests Trading Halt Ahead of Debt Funding Update

PremiumCompany Announcements

Nexalis Therapeutics Requests Trading Halt Ahead of Debt Funding Update

4d ago

Nexalis Therapeutics reshapes board as director steps down

PremiumCompany Announcements

Nexalis Therapeutics reshapes board as director steps down

13d ago

Nexalis Therapeutics Sets Virtual AGM to Vote on Board, Pay and Capital Mandates

PremiumCompany Announcements

Nexalis Therapeutics Sets Virtual AGM to Vote on Board, Pay and Capital Mandates

26d ago

Nexalis Therapeutics Sets Online-Only 2026 AGM and Moves to Digital Meeting Materials

PremiumCompany Announcements

Nexalis Therapeutics Sets Online-Only 2026 AGM and Moves to Digital Meeting Materials

26d ago

Nexalis calls virtual AGM with pay vote, potential board spill

PremiumCompany AnnouncementsNexalis calls virtual AGM with pay vote, potential board spill

26d ago

Nexalis Boosts Cash Reserves Despite R&D-Driven Outflows

Company Announcements

Nexalis Boosts Cash Reserves Despite R&D-Driven Outflows

26d ago

Nexalis shifts to active trial execution as rebrand caps pipeline expansion

Company Announcements

Nexalis shifts to active trial execution as rebrand caps pipeline expansion

26d ago

Nexalis Advances Inhaled CBD Anxiety Drug to Final Phase 1 Cohort

PremiumCompany Announcements

Nexalis Advances Inhaled CBD Anxiety Drug to Final Phase 1 Cohort

28d ago

Nexalis Screens First Patient in Phase 2 IRX-211 Trial for Breakthrough Cancer Pain

PremiumCompany Announcements

Nexalis Screens First Patient in Phase 2 IRX-211 Trial for Breakthrough Cancer Pain

1M ago

Nexalis Advances Phase 1 Trial of Inhaled CBD Therapy for Panic Disorder

PremiumCompany Announcements

Nexalis Advances Phase 1 Trial of Inhaled CBD Therapy for Panic Disorder

1M ago

Nexalis Therapeutics Confirms Corporate Structure and ASX Listing in Annual Report

PremiumCompany Announcements

Nexalis Therapeutics Confirms Corporate Structure and ASX Listing in Annual Report

2M ago

Nexalis Therapeutics Details Governance Framework and ASX Compliance

PremiumCompany AnnouncementsNexalis Therapeutics Details Governance Framework and ASX Compliance

2M ago

Nexalis to Showcase Inhaled Therapy Pipeline at NWR Virtual Healthcare Conference

Company Announcements

Nexalis to Showcase Inhaled Therapy Pipeline at NWR Virtual Healthcare Conference

2M ago

Nexalis starts first-in-human trial of inhaled CBD therapy for panic disorder

Company Announcements

Nexalis starts first-in-human trial of inhaled CBD therapy for panic disorder

2M ago

Nexalis starts first-in-human trial of inhaled CBD therapy for panic disorder

PremiumCompany Announcements

Nexalis starts first-in-human trial of inhaled CBD therapy for panic disorder

3M ago

Nexalis Therapeutics Loss Widens as Net Tangible Assets Slide Further

PremiumCompany Announcements

Nexalis Therapeutics Loss Widens as Net Tangible Assets Slide Further

3M ago

Nexalis Issues New Shares as It Accelerates Clinical Drug Programs

PremiumCompany Announcements

Nexalis Issues New Shares as It Accelerates Clinical Drug Programs

3M ago

Nexalis Therapeutics Seeks ASX Quotation for 780,000 New Shares

PremiumCompany Announcements

Nexalis Therapeutics Seeks ASX Quotation for 780,000 New Shares

3M ago

Nexalis Therapeutics Plans Placement of 780,000 New Shares

PremiumCompany AnnouncementsNexalis Therapeutics Plans Placement of 780,000 New Shares

3M ago

Nexalis pays advisory fees in shares to preserve cash for clinical pipeline

Company Announcements

Nexalis pays advisory fees in shares to preserve cash for clinical pipeline

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >